Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
28.67
-0.27 (-0.93%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
30,725,163
Open
29.05
Bid (Size)
28.65 (28)
Ask (Size)
28.67 (2)
Prev. Close
28.94
Today's Range
28.53 - 29.08
52wk Range
25.20 - 34.11
Shares Outstanding
5,606,688,356
Dividend Yield
5.72%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
Today 14:51 EDT
HHS announced lower costs for 54 Medicare Part B drugs starting in October 2024, part of the Inflation Reduction Act's rebate program, which aims to curb rising drug prices and reduce out-of-pocket...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
The Covid Era Tech Promises To Reinvent Cancer Treatment
Today 14:11 EDT
Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story.
Via
Benzinga
Exposures
COVID-19
Performance
YTD
-3.57%
-3.57%
1 Month
+1.31%
+1.31%
3 Month
+3.02%
+3.02%
6 Month
+4.07%
+4.07%
1 Year
-15.53%
-15.53%
More News
Read More
Transforming Alzheimer’s Treatment: Innovative Combinations to Boost Cognition
Today 10:05 EDT
Via
Investor Brand Network
Transforming Alzheimer’s Treatment: Innovative Combinations to Boost Cognition
Today 8:30 EDT
Via
FinancialNewsMedia
Pfizer Divests $3.3B Stake In Sensodyne Toothpaste And Panadol Painkiller Maker Haleon
Today 6:25 EDT
Via
Benzinga
Top 3 Discounted Value Stocks Worth Buying Now
September 30, 2024
Via
Talk Markets
Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate
September 30, 2024
Via
Benzinga
Exposures
Product Safety
Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
September 30, 2024
Via
Benzinga
Exposures
COVID-19
Is Summit Therapeutics Stock a Buy?
September 30, 2024
Via
The Motley Fool
Pfizer Unusual Options Activity
September 24, 2024
Via
Benzinga
15 Best Dividend Stocks for Lifelong Passive Income
September 30, 2024
Via
The Motley Fool
3 Surprisingly Underrated Stocks to Buy Right Now
September 28, 2024
Via
The Motley Fool
Pfizer Voluntarily Withdraws Sickle Cell Disease Treatment Oxbryta From Global Market Due To Painful Disease Complication, Deaths
September 26, 2024
Via
Benzinga
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
September 26, 2024
Via
Investor's Business Daily
2 High-Yield Dividend Stocks That Can Deliver a Lifetime of Passive Income
September 26, 2024
Via
The Motley Fool
3 Ultra-High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
September 26, 2024
Via
The Motley Fool
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets
September 25, 2024
From
Pfizer Inc.
Via
Business Wire
1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid
September 25, 2024
Via
The Motley Fool
3 Ultra-Cheap Stocks That Could Get a Boost From Fed Rate Cuts
September 24, 2024
Via
The Motley Fool
Topics
Economy
Exposures
Interest Rates
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Via
Benzinga
Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate
September 23, 2024
Via
Benzinga
2 Beaten-Down Stocks to Buy and Hold for a Decade
September 23, 2024
Via
The Motley Fool
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
Via
Benzinga
3 Dirt Cheap Stocks to Buy Right Now
September 21, 2024
Via
The Motley Fool
Pfizer Advances On Its Cancer Journey
September 20, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.